In their evaluation, the Committee will consider the following criteria:
Criterion 1: Evaluation of the Applicant
- Potential for a career in cardiovascular medicine and other comorbid conditions
- Academic record
- Prior research experience and/or publications
- Clearly written presentation supporting the research need
Criterion 2: Scientific Environment and Institutional Support
- Letter of Support from the Division Chief or Department Chair that confirms that the proposed scientific environment will contribute to the probability of success and that the institution is willing and able to commit sufficient resources for the conduct of the research.
- Does the proposed scientific environment contribute to the probability of success and is the institution willing and able to commit the resources necessary for the Applicant to complete the proposed research, including sufficient projected time?
Criterion 3: Evaluation of the Proposal
- Innovation and Significance: Is the proposed research new and original, and does it address an important question/issue related to cardiovascular disease or pulmonary arterial hypertension and one of the following areas: HIV, liver disease, rheumatologic diseases, and inflammatory bowel disease? Will this study have an effect on concepts, methods, and/or technologies related to research in cardiovascular or pulmonary arterial hypertension comorbidities in individuals suffering from HIV infection, liver disease, rheumatologic diseases, or inflammatory bowel disease?
- Approach: Are the conceptual framework, design, methods, and analyses adequately developed, well-integrated, well-reasoned, feasible (as determined by preliminary data or the expertise available), and appropriate to the aims of the project? Does the Applicant acknowledge potential problem areas and consider alternative tactics?
- Feasibility: Can the project, as described in the submitted proposal and budget, be accomplished within the timeframe of the award?